Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanostart-owned MagForce publishes study results of Nano-Cancer® therapy in leading medical journal

Abstract:
* Detailed information shared with international medical and scientific community
* European product launch scheduled for first quarter of 2011
* Further strategic steps in planning

Nanostart-owned MagForce publishes study results of Nano-Cancer® therapy in leading medical journal

Berlin / Frankfurt | Posted on September 22nd, 2010

The internationally renowned Journal of Neuro-Oncology has published the results of a clinical study by MagForce Nanotechnologies AG (Frankfurt Stock Exchange:MF6), a majority-owned portfolio company of Nanostart AG, demonstrating the effectiveness of its Nano-Cancer® therapy in the treatment of patients with recurrent glioblastoma. These clinical trials served as the basis for EU regulatory approval, received in June 2010, of this revolutionary new approach to treating solid tumors.

The Journal of Neuro-Oncology is an international multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research.

With this publication in the Journal of Neuro-Oncology, the detailed results of clinical trials demonstrating the effectiveness of Nano-Cancer® therapy have now for the first time been shared with the international scientific and medical community.

According to statements made by Dr. Peter Heinrich, CEO of MagForce Nanotechnologies, the company is currently planning further strategic steps. Product introduction, starting with the German market, is schedule to commence in the first quarter of 2011. Sale and marketing teams for product commercialization, as well as the needed infrastructure, are currently being put in place. In addition, other clinical trials will be initiated, and the company will be structured to optimally serve the international market.

The full journal article, entitled "Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme," may be found at www.springerlink.com/content/u27ll42612302123/ or www.ncbi.nlm.nih.gov/pubmed/20845061

The study reported on the treatment of 59 cancer patients suffering from recurrent glioblastoma, a particularly aggressive form of brain tumor. Using Nano-Cancer® therapy in conjunction with radiotherapy, the median survival time of the patient group was 13.4 months, compared to 6.2 months using existing conventional therapies in a control study. The median survival time was thus more than doubled, a significant increase. In addition, the new therapy offers the advantage of minimal side effects and reduced patient discomfort compared to existing therapeutic alternatives.

####

For more information, please click here

Contacts:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
D-60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122

Copyright © Nanostart

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

The Hiden EQP Plasma Diagnostic with on-board MCA July 22nd, 2014

Iran to Hold 3rd Int'l Forum on Nanotechnology Economy July 22nd, 2014

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Nanobiotechnology

Production of Non-Virus Nanocarriers with Highest Amount of Gene Delivery July 17th, 2014

Physicists Use Computer Models to Reveal Quantum Effects in Biological Oxygen Transport: The team solved a long-standing question by explaining why oxygen – and not deadly carbon monoxide – preferably binds to the proteins that transport it around the body. July 17th, 2014

Tiny DNA pyramids enter bacteria easily -- and deliver a deadly payload July 9th, 2014

Artificial cilia: Scientists from Kiel University develop nano-structured transportation system July 4th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE